1. Home
  2. VSTM vs SPFI Comparison

VSTM vs SPFI Comparison

Compare VSTM & SPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSTM
  • SPFI
  • Stock Information
  • Founded
  • VSTM 2010
  • SPFI 1941
  • Country
  • VSTM United States
  • SPFI United States
  • Employees
  • VSTM N/A
  • SPFI N/A
  • Industry
  • VSTM Biotechnology: Pharmaceutical Preparations
  • SPFI Major Banks
  • Sector
  • VSTM Health Care
  • SPFI Finance
  • Exchange
  • VSTM Nasdaq
  • SPFI Nasdaq
  • Market Cap
  • VSTM 662.8M
  • SPFI 662.8M
  • IPO Year
  • VSTM 2012
  • SPFI 2019
  • Fundamental
  • Price
  • VSTM $9.92
  • SPFI $40.35
  • Analyst Decision
  • VSTM Strong Buy
  • SPFI Buy
  • Analyst Count
  • VSTM 9
  • SPFI 3
  • Target Price
  • VSTM $13.38
  • SPFI $41.67
  • AVG Volume (30 Days)
  • VSTM 2.9M
  • SPFI 46.4K
  • Earning Date
  • VSTM 11-05-2025
  • SPFI 10-22-2025
  • Dividend Yield
  • VSTM N/A
  • SPFI 1.49%
  • EPS Growth
  • VSTM N/A
  • SPFI 19.09
  • EPS
  • VSTM N/A
  • SPFI 3.20
  • Revenue
  • VSTM $2,137,000.00
  • SPFI $199,001,000.00
  • Revenue This Year
  • VSTM $86.06
  • SPFI $13.41
  • Revenue Next Year
  • VSTM $395.22
  • SPFI $6.10
  • P/E Ratio
  • VSTM N/A
  • SPFI $12.61
  • Revenue Growth
  • VSTM N/A
  • SPFI 7.49
  • 52 Week Low
  • VSTM $2.40
  • SPFI $30.01
  • 52 Week High
  • VSTM $11.25
  • SPFI $42.38
  • Technical
  • Relative Strength Index (RSI)
  • VSTM 66.95
  • SPFI 54.88
  • Support Level
  • VSTM $8.71
  • SPFI $39.62
  • Resistance Level
  • VSTM $11.25
  • SPFI $41.91
  • Average True Range (ATR)
  • VSTM 0.64
  • SPFI 1.16
  • MACD
  • VSTM 0.05
  • SPFI -0.06
  • Stochastic Oscillator
  • VSTM 64.05
  • SPFI 53.71

About VSTM Verastem Inc.

Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.

About SPFI South Plains Financial Inc.

South Plains Financial Inc operates as a bank holding company. The company provides a wide range of commercial and consumer financial services to small and medium-sized businesses and individuals. The principal business activities include commercial and retail banking, along with insurance, investment, trust, and mortgage services. The company has one reportable segment: banking.

Share on Social Networks: